Navigation Links
InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
Date:9/12/2008

primary cell media.

(see http://www.Cellastim.com )

-- Lacromin -- Lacromin has been shown to replace bovine transferrin and

human transferrin in cell culture media. In addition, Lacromin is a

strong growth promotant as a cell culture ingredient in mammalian cell

culture media. (see http://www.Lacromin.com )

-- Lysobac -- Lysobac is a bacterial cell lysis agent that is more

efficient and more consistent compared to chicken lysozyme and provides

higher protein yield compared with mechanical cell lysis. Lysobac is

used in bacterial fermentation to improve recombinant protein

yields.(see http://www.Lysobac.com )

For more information about the InVitria line of products, please e-mail info@InVitria.com or call 1-800-916-8311.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related medicine technology :

1. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
2. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
5. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
6. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
7. AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
11. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Jennifer Dodson M D named 2009 AUA Foundation NIDDK NCI Surgeon Scientist Award winner 49928 1NYU Langone Medical Center awarded NIH grants totaling 241 560 000 8981 1NYU Langone Medical Center awarded NIH grants totaling 241 560 000 8981 2NYU Langone Medical Center awarded NIH grants totaling 241 560 000 8981 3Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 1Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 2Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 3